Novartis Shakes Up Leaders, Looks To Emerging Markets To Grow OTC Sales
This article was originally published in The Tan Sheet
Executive Summary
As part of the second major management shake-up in a year, Novartis is combining leadership roles for its consumer health division and veterinary medicines business under George Gunn, currently head of its animal health business